Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab + Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer

OBJECTIVE: To investigate the clinical efficacy and safety of albumin paclitaxel combined with intrapleural bevacizumab + lobaplatin for patients with non-squamous non-small cell lung cancer (NS-NSCLC) with malignant pleural effusion (MPE) and analyze prognostic factors. METHODS: A total of 126 NS-N...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Junjie, Mi, Xuguang, Liu, Ning, Yang, Ying, Qi, Zhaoxue, Li, Xiaonan, Lu, Xiaodan, Jiang, Xianzhuo, Yu, Yingying, Zhou, Ying, Ni, Zhiqiang, Fang, Yanqiu, Jin, Ningyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251141/
https://www.ncbi.nlm.nih.gov/pubmed/35794989
http://dx.doi.org/10.1155/2022/5901450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251141/
https://www.ncbi.nlm.nih.gov/pubmed/35794989
http://dx.doi.org/10.1155/2022/5901450

Ejemplares similares